Michele Marie Burns, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Poisons | 3 | 2023 | 34 | 2.000 |
Why?
|
Poisoning | 7 | 2020 | 249 | 1.650 |
Why?
|
Clonidine | 2 | 2020 | 164 | 1.410 |
Why?
|
Legislation, Drug | 2 | 2020 | 206 | 1.250 |
Why?
|
Cannabis | 3 | 2023 | 440 | 1.090 |
Why?
|
Antidotes | 5 | 2023 | 138 | 1.010 |
Why?
|
Poison Control Centers | 3 | 2023 | 72 | 1.010 |
Why?
|
Abortifacient Agents | 1 | 2023 | 12 | 0.910 |
Why?
|
Hypoglycemia | 2 | 2023 | 861 | 0.900 |
Why?
|
Detergents | 2 | 2020 | 230 | 0.890 |
Why?
|
Drug Compounding | 2 | 2020 | 242 | 0.860 |
Why?
|
Thiocyanates | 1 | 2022 | 70 | 0.840 |
Why?
|
Bradycardia | 2 | 2023 | 307 | 0.840 |
Why?
|
Hallucinogens | 2 | 2023 | 180 | 0.830 |
Why?
|
Antitussive Agents | 1 | 2021 | 17 | 0.820 |
Why?
|
Misoprostol | 1 | 2023 | 95 | 0.820 |
Why?
|
Performance-Enhancing Substances | 1 | 2022 | 29 | 0.800 |
Why?
|
Doping in Sports | 1 | 2022 | 63 | 0.800 |
Why?
|
Pharmacy | 1 | 2023 | 91 | 0.800 |
Why?
|
Pharmacies | 1 | 2023 | 150 | 0.790 |
Why?
|
Cannabinoids | 1 | 2024 | 166 | 0.790 |
Why?
|
Bupropion | 1 | 2023 | 303 | 0.780 |
Why?
|
Naloxone | 2 | 2020 | 367 | 0.750 |
Why?
|
Acidosis | 1 | 2022 | 270 | 0.720 |
Why?
|
Toxicology | 1 | 2020 | 106 | 0.690 |
Why?
|
Drug Contamination | 1 | 2020 | 147 | 0.690 |
Why?
|
Blood Coagulation Disorders | 1 | 2022 | 337 | 0.690 |
Why?
|
Long QT Syndrome | 1 | 2023 | 453 | 0.660 |
Why?
|
Chloroquine | 1 | 2020 | 279 | 0.660 |
Why?
|
Methadone | 2 | 2018 | 306 | 0.640 |
Why?
|
Cough | 1 | 2021 | 555 | 0.620 |
Why?
|
Artificial Intelligence | 2 | 2021 | 2213 | 0.590 |
Why?
|
Hypotension | 1 | 2023 | 884 | 0.590 |
Why?
|
Abortion, Induced | 1 | 2023 | 458 | 0.580 |
Why?
|
Dextroamphetamine | 1 | 2016 | 129 | 0.560 |
Why?
|
Caustics | 3 | 2020 | 30 | 0.560 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 412 | 0.550 |
Why?
|
Burns, Chemical | 3 | 2020 | 159 | 0.550 |
Why?
|
Sodium Bicarbonate | 1 | 2016 | 62 | 0.540 |
Why?
|
Pharmaceutical Preparations | 2 | 2023 | 1070 | 0.540 |
Why?
|
Sports | 1 | 2022 | 688 | 0.520 |
Why?
|
Psychotropic Drugs | 2 | 2023 | 894 | 0.520 |
Why?
|
Marijuana Smoking | 1 | 2018 | 253 | 0.500 |
Why?
|
Data Mining | 1 | 2020 | 537 | 0.500 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2016 | 125 | 0.500 |
Why?
|
Drug Industry | 1 | 2020 | 746 | 0.490 |
Why?
|
Esophageal Stenosis | 3 | 2020 | 195 | 0.480 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2023 | 1004 | 0.480 |
Why?
|
Vaccines | 1 | 2023 | 823 | 0.480 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2016 | 789 | 0.400 |
Why?
|
Evidence-Based Medicine | 2 | 2023 | 3611 | 0.390 |
Why?
|
Arrhythmias, Cardiac | 2 | 2023 | 2269 | 0.380 |
Why?
|
Child | 26 | 2023 | 77709 | 0.370 |
Why?
|
Heart Conduction System | 1 | 2016 | 1047 | 0.360 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2016 | 964 | 0.360 |
Why?
|
Heart Diseases | 1 | 2021 | 2789 | 0.320 |
Why?
|
Central Nervous System Stimulants | 1 | 2016 | 1148 | 0.310 |
Why?
|
Epilepsy | 1 | 2023 | 3310 | 0.310 |
Why?
|
Antiviral Agents | 1 | 2020 | 2987 | 0.300 |
Why?
|
Humans | 55 | 2024 | 744366 | 0.300 |
Why?
|
Immunotherapy | 1 | 2023 | 4446 | 0.300 |
Why?
|
Communication | 1 | 2020 | 3750 | 0.280 |
Why?
|
Research Design | 1 | 2022 | 5984 | 0.280 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9274 | 0.270 |
Why?
|
Narcotic Antagonists | 3 | 2018 | 562 | 0.260 |
Why?
|
Heart Rate | 1 | 2016 | 4092 | 0.250 |
Why?
|
Doxepin | 1 | 2023 | 16 | 0.240 |
Why?
|
Plant Poisoning | 1 | 2023 | 13 | 0.240 |
Why?
|
Eye Burns | 1 | 2005 | 103 | 0.240 |
Why?
|
Eating | 2 | 2023 | 1536 | 0.230 |
Why?
|
Foodborne Diseases | 1 | 2023 | 39 | 0.230 |
Why?
|
Ophthalmic Solutions | 1 | 2005 | 317 | 0.230 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2023 | 106 | 0.220 |
Why?
|
Hydrogen Sulfide | 1 | 2004 | 137 | 0.220 |
Why?
|
Charcoal | 2 | 2016 | 62 | 0.220 |
Why?
|
Adolescent | 16 | 2023 | 85779 | 0.210 |
Why?
|
Mifepristone | 1 | 2023 | 150 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3135 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3242 | 0.200 |
Why?
|
Cyanides | 1 | 2022 | 83 | 0.200 |
Why?
|
Ataxia | 1 | 2023 | 304 | 0.200 |
Why?
|
Child, Preschool | 12 | 2023 | 41005 | 0.190 |
Why?
|
Borates | 1 | 2020 | 21 | 0.190 |
Why?
|
Sodium Hypochlorite | 1 | 2020 | 30 | 0.190 |
Why?
|
Tachycardia | 1 | 2023 | 619 | 0.190 |
Why?
|
International Normalized Ratio | 1 | 2022 | 367 | 0.190 |
Why?
|
Analgesics, Opioid | 4 | 2022 | 3677 | 0.190 |
Why?
|
Phenol | 1 | 2020 | 43 | 0.190 |
Why?
|
Seizures | 2 | 2023 | 2859 | 0.190 |
Why?
|
Environmental Health | 1 | 2023 | 278 | 0.190 |
Why?
|
Carbamazepine | 2 | 2017 | 229 | 0.180 |
Why?
|
Vitamin K | 1 | 2022 | 295 | 0.180 |
Why?
|
Anti-Obesity Agents | 1 | 2023 | 217 | 0.180 |
Why?
|
Fentanyl | 2 | 2022 | 409 | 0.180 |
Why?
|
Esophageal Perforation | 1 | 2020 | 69 | 0.180 |
Why?
|
Knowledge Bases | 1 | 2020 | 85 | 0.180 |
Why?
|
Household Products | 1 | 2019 | 26 | 0.180 |
Why?
|
Rhode Island | 1 | 2020 | 347 | 0.180 |
Why?
|
Calcium Channel Blockers | 1 | 2023 | 692 | 0.180 |
Why?
|
Buprenorphine | 2 | 2018 | 640 | 0.180 |
Why?
|
Ammonia | 1 | 2020 | 239 | 0.170 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2020 | 87 | 0.170 |
Why?
|
Poisson Distribution | 1 | 2020 | 513 | 0.170 |
Why?
|
Vocabulary, Controlled | 1 | 2020 | 170 | 0.170 |
Why?
|
Rectum | 1 | 2023 | 904 | 0.160 |
Why?
|
Vomiting | 2 | 2019 | 637 | 0.160 |
Why?
|
Hypnotics and Sedatives | 2 | 2017 | 1162 | 0.160 |
Why?
|
Carbon Monoxide Poisoning | 1 | 2018 | 66 | 0.160 |
Why?
|
Antidepressive Agents, Tricyclic | 2 | 2016 | 434 | 0.160 |
Why?
|
Critical Care | 2 | 2023 | 2647 | 0.150 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2023 | 1240 | 0.150 |
Why?
|
Infant | 9 | 2023 | 35134 | 0.150 |
Why?
|
Weather | 1 | 2018 | 228 | 0.150 |
Why?
|
Massachusetts | 2 | 2020 | 8662 | 0.150 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11718 | 0.140 |
Why?
|
Analgesics | 2 | 2021 | 1040 | 0.140 |
Why?
|
Barbiturates | 1 | 2017 | 114 | 0.140 |
Why?
|
Markov Chains | 1 | 2020 | 969 | 0.140 |
Why?
|
Narcotics | 1 | 2018 | 343 | 0.140 |
Why?
|
Authorship | 1 | 2019 | 271 | 0.140 |
Why?
|
History, 20th Century | 2 | 2020 | 2740 | 0.130 |
Why?
|
Diphenhydramine | 1 | 2015 | 63 | 0.130 |
Why?
|
Drug Costs | 1 | 2023 | 1105 | 0.130 |
Why?
|
United States | 8 | 2023 | 69872 | 0.130 |
Why?
|
Sodium Channel Blockers | 1 | 2016 | 176 | 0.130 |
Why?
|
Female | 19 | 2023 | 380193 | 0.120 |
Why?
|
Opiate Substitution Treatment | 1 | 2018 | 404 | 0.120 |
Why?
|
Male | 16 | 2023 | 350115 | 0.120 |
Why?
|
History, 21st Century | 1 | 2020 | 1534 | 0.120 |
Why?
|
Athletes | 1 | 2022 | 1093 | 0.120 |
Why?
|
Warfarin | 1 | 2022 | 1497 | 0.120 |
Why?
|
Medication Errors | 1 | 2020 | 798 | 0.120 |
Why?
|
Occupational Exposure | 1 | 2004 | 1793 | 0.110 |
Why?
|
Coma | 1 | 2017 | 475 | 0.110 |
Why?
|
Antimony Potassium Tartrate | 1 | 2012 | 3 | 0.110 |
Why?
|
Retrospective Studies | 7 | 2023 | 77460 | 0.110 |
Why?
|
Young Adult | 5 | 2023 | 56429 | 0.110 |
Why?
|
Disasters | 1 | 2018 | 511 | 0.110 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2017 | 632 | 0.100 |
Why?
|
Publishing | 1 | 2019 | 833 | 0.100 |
Why?
|
Health Status Indicators | 1 | 2017 | 970 | 0.100 |
Why?
|
Pandemics | 2 | 2023 | 8385 | 0.100 |
Why?
|
Consciousness Disorders | 1 | 2015 | 418 | 0.100 |
Why?
|
Drug Interactions | 1 | 2016 | 1460 | 0.100 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1637 | 0.100 |
Why?
|
Glucocorticoids | 1 | 2020 | 2108 | 0.090 |
Why?
|
Prescription Drugs | 1 | 2017 | 595 | 0.090 |
Why?
|
Hemorrhage | 1 | 2022 | 3461 | 0.090 |
Why?
|
Medical Order Entry Systems | 1 | 2016 | 545 | 0.090 |
Why?
|
Anticonvulsants | 2 | 2016 | 1916 | 0.090 |
Why?
|
Antimalarials | 1 | 2016 | 905 | 0.080 |
Why?
|
Diagnosis, Differential | 4 | 2017 | 12961 | 0.080 |
Why?
|
Disease Outbreaks | 1 | 2018 | 1771 | 0.080 |
Why?
|
Adult | 8 | 2023 | 214052 | 0.080 |
Why?
|
Suicide, Attempted | 1 | 2016 | 1218 | 0.080 |
Why?
|
Action Potentials | 1 | 2016 | 1806 | 0.080 |
Why?
|
Databases, Factual | 1 | 2023 | 7730 | 0.080 |
Why?
|
Boston | 1 | 2020 | 9312 | 0.070 |
Why?
|
Anticoagulants | 1 | 2022 | 4600 | 0.070 |
Why?
|
Software | 1 | 2021 | 4441 | 0.070 |
Why?
|
Recovery of Function | 1 | 2016 | 2926 | 0.070 |
Why?
|
Delirium | 1 | 2017 | 1610 | 0.070 |
Why?
|
Pediatrics | 2 | 2017 | 3475 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8642 | 0.060 |
Why?
|
Infant, Newborn | 3 | 2019 | 25628 | 0.060 |
Why?
|
Confined Spaces | 1 | 2004 | 10 | 0.060 |
Why?
|
Incidence | 2 | 2020 | 20952 | 0.060 |
Why?
|
Histoplasmosis | 1 | 2004 | 66 | 0.060 |
Why?
|
Androstanes | 1 | 2023 | 21 | 0.060 |
Why?
|
2,4-Dinitrophenol | 1 | 2023 | 13 | 0.060 |
Why?
|
Dinitrophenols | 1 | 2023 | 57 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2018 | 2064 | 0.060 |
Why?
|
Intensive Care Units, Pediatric | 2 | 2023 | 981 | 0.060 |
Why?
|
High-Frequency Ventilation | 1 | 2004 | 87 | 0.060 |
Why?
|
Therapeutic Irrigation | 1 | 2005 | 301 | 0.060 |
Why?
|
Electrocardiography | 1 | 2016 | 6442 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2021 | 19905 | 0.050 |
Why?
|
Cohort Studies | 3 | 2020 | 40559 | 0.050 |
Why?
|
Acetylcysteine | 1 | 2023 | 271 | 0.050 |
Why?
|
Internship and Residency | 1 | 2022 | 5791 | 0.050 |
Why?
|
Pregnancy | 1 | 2023 | 29144 | 0.050 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2004 | 367 | 0.050 |
Why?
|
Sucralfate | 1 | 2020 | 12 | 0.050 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2004 | 657 | 0.050 |
Why?
|
Alkalies | 1 | 2020 | 52 | 0.050 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2005 | 2556 | 0.040 |
Why?
|
Toxicity Tests | 1 | 2000 | 121 | 0.040 |
Why?
|
Acids | 1 | 2020 | 127 | 0.040 |
Why?
|
Product Labeling | 1 | 2020 | 79 | 0.040 |
Why?
|
Hospitalization | 2 | 2016 | 10259 | 0.040 |
Why?
|
Mitomycin | 1 | 2020 | 259 | 0.040 |
Why?
|
Naltrexone | 1 | 2001 | 307 | 0.040 |
Why?
|
Acetaminophen | 1 | 2023 | 545 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2004 | 1851 | 0.040 |
Why?
|
Hospital Mortality | 2 | 2023 | 5316 | 0.040 |
Why?
|
Risk Factors | 4 | 2023 | 72296 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 25039 | 0.040 |
Why?
|
Anesthetics, Intravenous | 1 | 2001 | 417 | 0.040 |
Why?
|
Canada | 1 | 2023 | 2065 | 0.040 |
Why?
|
Hemodiafiltration | 1 | 2017 | 20 | 0.040 |
Why?
|
Occupational Health | 1 | 2004 | 808 | 0.040 |
Why?
|
Endoscopy, Digestive System | 1 | 2020 | 345 | 0.040 |
Why?
|
Decontamination | 1 | 2017 | 69 | 0.040 |
Why?
|
Plasmapheresis | 1 | 2017 | 211 | 0.040 |
Why?
|
Peer Review, Research | 1 | 2019 | 329 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1531 | 0.030 |
Why?
|
Prognosis | 1 | 2016 | 29060 | 0.030 |
Why?
|
Government Regulation | 1 | 2020 | 522 | 0.030 |
Why?
|
Renal Dialysis | 2 | 2017 | 1783 | 0.030 |
Why?
|
Risk Assessment | 1 | 2016 | 23336 | 0.030 |
Why?
|
Esophagus | 1 | 2020 | 1019 | 0.030 |
Why?
|
Emergency Service, Hospital | 2 | 2023 | 7658 | 0.030 |
Why?
|
Oximetry | 1 | 2016 | 471 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2022 | 1078 | 0.030 |
Why?
|
Length of Stay | 2 | 2016 | 6311 | 0.030 |
Why?
|
Self Report | 1 | 2023 | 3553 | 0.030 |
Why?
|
Ambulatory Care | 1 | 2023 | 2708 | 0.030 |
Why?
|
Liver Failure, Acute | 1 | 2012 | 165 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2019 | 1856 | 0.020 |
Why?
|
Steroids | 1 | 2016 | 930 | 0.020 |
Why?
|
Odds Ratio | 1 | 2023 | 9849 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2016 | 63107 | 0.020 |
Why?
|
Lung Diseases | 1 | 2019 | 1887 | 0.020 |
Why?
|
Operating Rooms | 1 | 2016 | 817 | 0.020 |
Why?
|
Suicide | 1 | 2019 | 1474 | 0.020 |
Why?
|
Periodicals as Topic | 1 | 2019 | 1431 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 53290 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 2016 | 1199 | 0.020 |
Why?
|
Registries | 1 | 2023 | 8091 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2016 | 1775 | 0.020 |
Why?
|
Clinical Competence | 1 | 2022 | 4687 | 0.020 |
Why?
|
Trinidad and Tobago | 1 | 2004 | 11 | 0.020 |
Why?
|
Chills | 1 | 2004 | 16 | 0.020 |
Why?
|
Oxygen | 1 | 2016 | 4189 | 0.020 |
Why?
|
Antigens, Fungal | 1 | 2004 | 70 | 0.020 |
Why?
|
Critical Illness | 1 | 2017 | 2670 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2016 | 3680 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14723 | 0.010 |
Why?
|
Midazolam | 1 | 2001 | 270 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2004 | 847 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2000 | 980 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7182 | 0.010 |
Why?
|
Fever | 1 | 2004 | 1616 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2004 | 2232 | 0.010 |
Why?
|
Time Factors | 1 | 2016 | 40075 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 57776 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2001 | 1917 | 0.010 |
Why?
|
Aged | 1 | 2019 | 163288 | 0.000 |
Why?
|
Middle Aged | 1 | 2019 | 213390 | 0.000 |
Why?
|